Northey Luke Cameron, Shiraev Timothy, Omari Abdullah
School of Medicine Sydney, The University of Notre Dame Australia, Sydney, Australia.
Department of Vascular Medicine, St. Vincent's General Hospital, Sydney, Australia.
J Emerg Trauma Shock. 2015 Jan-Mar;8(1):55-7. doi: 10.4103/0974-2700.145395.
Intraosseous access is an alternative route of pharmacotherapy during cardiopulmonary resuscitation. Extracorporeal membrane oxygenation (ECMO) provides cardiac and respiratory support when conventional therapies fail. This case reports the use of intraosseous thrombolysis and ECMO in a patient with acute massive pulmonary embolism (PE). A 34-year-old female presented to the emergency department with sudden onset severe shortness of breath. Due to difficulty establishing intravenous access, an intraosseous needle was inserted into the left tibia. Echocardiography identified severe right ventricular dilatation with global systolic impairment and failure, indicative of PE. Due to the patient's hemodynamic compromise a recombinant tissue plasminogen activator (Alteplase) bolus was administered through the intraosseous route. After transfer to the intensive care unit, venous-arterial ECMO was initiated as further therapy. The patient recovered and was discharged 36 days after admission. This is the first report of combination intraosseous thrombolysis and ECMO as salvage therapy for massive PE.
骨内通路是心肺复苏期间药物治疗的一种替代途径。当传统疗法无效时,体外膜肺氧合(ECMO)可提供心脏和呼吸支持。本病例报告了一名急性大面积肺栓塞(PE)患者使用骨内溶栓和ECMO的情况。一名34岁女性因突发严重气短就诊于急诊科。由于难以建立静脉通路,将骨内针插入左胫骨。超声心动图显示严重的右心室扩张伴整体收缩功能障碍和衰竭,提示肺栓塞。由于患者血流动力学不稳定,通过骨内途径给予重组组织型纤溶酶原激活剂(阿替普酶)推注。转入重症监护病房后,启动静脉-动脉ECMO作为进一步治疗。患者康复,入院36天后出院。这是首例将骨内溶栓和ECMO联合作为大面积肺栓塞挽救治疗的报告。